ATE392476T1 - Dna immunisierung gegen chlamydia infektion - Google Patents

Dna immunisierung gegen chlamydia infektion

Info

Publication number
ATE392476T1
ATE392476T1 AT00962134T AT00962134T ATE392476T1 AT E392476 T1 ATE392476 T1 AT E392476T1 AT 00962134 T AT00962134 T AT 00962134T AT 00962134 T AT00962134 T AT 00962134T AT E392476 T1 ATE392476 T1 AT E392476T1
Authority
AT
Austria
Prior art keywords
stk
host
immunization against
dna immunization
chlamydia infection
Prior art date
Application number
AT00962134T
Other languages
English (en)
Inventor
Robert Brunham
Original Assignee
Univ Manitoba
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Manitoba filed Critical Univ Manitoba
Application granted granted Critical
Publication of ATE392476T1 publication Critical patent/ATE392476T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00962134T 1999-09-22 2000-09-21 Dna immunisierung gegen chlamydia infektion ATE392476T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/401,780 US6632663B1 (en) 1999-09-22 1999-09-22 DNA immunization against chlamydia infection

Publications (1)

Publication Number Publication Date
ATE392476T1 true ATE392476T1 (de) 2008-05-15

Family

ID=23589205

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00962134T ATE392476T1 (de) 1999-09-22 2000-09-21 Dna immunisierung gegen chlamydia infektion

Country Status (8)

Country Link
US (2) US6632663B1 (de)
EP (1) EP1222283B1 (de)
AT (1) ATE392476T1 (de)
AU (1) AU774309B2 (de)
CA (1) CA2385655C (de)
DE (1) DE60038620T2 (de)
NZ (1) NZ518283A (de)
WO (1) WO2001021811A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6686339B1 (en) 1998-08-20 2004-02-03 Aventis Pasteur Limited Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
WO2000011180A1 (en) 1998-08-20 2000-03-02 Connaught Laboratories Limited NUCLEIC ACID MOLECULES ENCODING POMP91A PROTEIN OF $i(CHLAMYDIA)
CA2340330A1 (en) 1998-08-20 2000-03-02 Aventis Pasteur Limited Nucleic acid molecules encoding inclusion membrane protein c of chlamydia
US6649370B1 (en) 1998-10-28 2003-11-18 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
US6607730B1 (en) 1998-11-02 2003-08-19 Aventis Pasteur Limited/Aventis Pasteur Limitee Chlamydia antigens and corresponding DNA fragments and uses thereof
WO2000032784A1 (en) 1998-12-01 2000-06-08 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
AU772356B2 (en) * 1998-12-04 2004-04-22 Aventis Pasteur Limited Two-step immunization procedure against chlamydia infection
AU769293B2 (en) 1998-12-08 2004-01-22 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US20020061848A1 (en) 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
GB9828000D0 (en) 1998-12-18 1999-02-10 Chiron Spa Antigens
US7297341B1 (en) 1998-12-23 2007-11-20 Sanofi Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
US6808713B1 (en) 1998-12-28 2004-10-26 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
AU774902B2 (en) 1998-12-28 2004-07-15 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
GB9902555D0 (en) 1999-02-05 1999-03-24 Neutec Pharma Plc Medicament
WO2000055326A1 (en) 1999-03-12 2000-09-21 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
EP1177301B1 (de) 1999-05-03 2007-10-10 Sanofi Pasteur Limited Chlamydia-antigene und entsprechende dna-fragmente und deren verwendungen
CA2385325C (en) 1999-09-20 2012-04-10 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
ATE463575T1 (de) 1999-12-22 2010-04-15 Aventis Pasteur Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen
DE60133190T2 (de) 2000-04-21 2009-04-02 CORIXA CORP., Wilmington Verbindungen und verfahren zur behandlung und diagnose von chlamydia-infektionen
ATE348892T1 (de) 2000-05-08 2007-01-15 Sanofi Pasteur Ltd Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen
CA2414884A1 (en) 2000-07-03 2002-01-10 Chiron S.P.A. Immunisation against chlamydia pneumoniae
FR2903605A1 (fr) 2006-07-12 2008-01-18 Sanofi Pasteur Sa Methode d'immunisation contre les quatres serotypes de la dengue
FR2906724B1 (fr) 2006-10-04 2009-03-20 Sanofi Pasteur Sa Methode d'immunisation contre les 4 serotypes de la dengue.
FR2909286B1 (fr) 2006-12-01 2012-06-08 Sanofi Pasteur Methode d'immunisation contre les 4 serotypes de la dengue
RU2011140508A (ru) 2009-03-06 2013-04-20 Новартис Аг Антигены хламидии

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3650571T2 (de) 1985-01-14 1997-02-27 Chiron Corp Hauptprotein der Aussenmembran von Chlamydia
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US6001372A (en) * 1995-08-25 1999-12-14 Wisconsin Alumni Research Foundation Antigenic peptides of Chlamydia trachomatis
NZ334114A (en) 1996-07-12 2000-06-23 Univ Manitoba DNA immunization against chlamydia infection comprising a major outer membrane protein (MOMP) or a MOMP fragment linked to a promoter sequence
WO1999027105A2 (en) 1997-11-21 1999-06-03 Genset Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
KR100735653B1 (ko) * 1997-11-28 2007-07-06 세로노 제네틱스 인스티튜트 에스.에이. 클라미디아 트라코마티스 게놈 서열과 폴리펩티드, 이의단편 및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도
JP2002529069A (ja) 1998-11-12 2002-09-10 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア クラミジア・ニューモニエのゲノム配列
US6565856B1 (en) 1998-12-08 2003-05-20 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
AU769293B2 (en) 1998-12-08 2004-01-22 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US20020061848A1 (en) 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
GB9828000D0 (en) 1998-12-18 1999-02-10 Chiron Spa Antigens
GB9902555D0 (en) 1999-02-05 1999-03-24 Neutec Pharma Plc Medicament
EP1177301B1 (de) 1999-05-03 2007-10-10 Sanofi Pasteur Limited Chlamydia-antigene und entsprechende dna-fragmente und deren verwendungen
CA2385325C (en) 1999-09-20 2012-04-10 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
US6294265B1 (en) 1999-09-23 2001-09-25 Rademate Ltd. Hydrophobic biodegradable cellulose containing composite materials
ATE463575T1 (de) 1999-12-22 2010-04-15 Aventis Pasteur Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen
DE60133190T2 (de) 2000-04-21 2009-04-02 CORIXA CORP., Wilmington Verbindungen und verfahren zur behandlung und diagnose von chlamydia-infektionen
ATE348892T1 (de) 2000-05-08 2007-01-15 Sanofi Pasteur Ltd Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen
CA2414884A1 (en) 2000-07-03 2002-01-10 Chiron S.P.A. Immunisation against chlamydia pneumoniae

Also Published As

Publication number Publication date
WO2001021811A1 (en) 2001-03-29
CA2385655A1 (en) 2001-03-29
NZ518283A (en) 2003-10-31
AU774309B2 (en) 2004-06-24
EP1222283B1 (de) 2008-04-16
US7229975B1 (en) 2007-06-12
EP1222283A1 (de) 2002-07-17
AU7399200A (en) 2001-04-24
DE60038620T2 (de) 2009-06-10
DE60038620D1 (de) 2008-05-29
CA2385655C (en) 2010-08-24
US6632663B1 (en) 2003-10-14

Similar Documents

Publication Publication Date Title
DE60038620D1 (de) Dna immunisierung gegen chlamydia infektion
ATE312920T1 (de) Dna immunisierung gegen chlamydia infektion
BR0007414A (pt) Expressão e exportação de proteìnas antiobesidade como proteìnas de fusão fc
ATE325200T1 (de) Chimäre adenoviren
AU4078599A (en) Expression vectors for stimulating an immune response and methods of using the same
PE20060277A1 (es) Adenovirus quimericos en el tratamiento del cancer
BR0208874A (pt) Proteìnas superficiais de streptococcus pyogenes
WO2001046224A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
ITFI920052A1 (it) Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico.
TR200401186T4 (tr) Rekombinant bir RNA-virüs oluşumunu yönlendirebilen nükleik asit sekansları içerikli suni kromozom yapıları.
DK1792982T3 (da) Codon-optimeret phosphatase og ekspression heraf i gær
GB9922361D0 (en) Generating an immune response to an antigen
DE69230671T2 (de) Impfstoffe gegen actinobacillus pleuropneumonie
WO1999051745A3 (en) Dna immunization against chlamydia infection
ES2148164T3 (es) Cepa atenuada de vacuna del virus del sarampion, que contiene una secuencia nucleotidica especifica y procedimiento para su identificacion.
DK0843731T3 (da) Adenovirusvektorer til genterapi
FI961202A (fi) Grb3-3-geeni, sen variantteja ja niiden käyttöjä
WO2001083737A3 (en) Porcine adenovirus type 5 vector and vaccine
CY1107845T1 (el) Γενετικα εμβολια με ανοσοενισχυτικο
WO1999057284A3 (en) Attenuated influenza viruses
Ge et al. Cloning and Sequence Analysis of the 22‐kDa Antigen Genes of Orientia tsutsugamushi Strains Kato, TA763, AFSC 7, 18–032460, TH1814, and MAK 119
MXPA01001639A (es) Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos.
MD2149G2 (ro) Primer oligonucleotidic pentru depistarea ARN-ului virusului hepatitei C
HU9900534D0 (en) Aviadenovirus
WO2003031470A3 (de) Dna-expressionskonstrukt zur behandlung von infektionen mit leishmaniose

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties